Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients

Development of resistance to imatinib mesylate (IM) in chronic myeloid leukemia (CML) patients is mediated by different mechanisms that can be classified as BCR-ABL dependent or BCR-ABL independent pathways. BCR-ABL dependent mechanisms are most frequently associated with point mutations in tyrosine...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Elias, Marjanu Hikmah, Baba, Abdul Aziz, Husin, Azlan, Abdullah, Abu Dzarr, Hassan, Rosline, Sim, Goh Ai, Wahid, S. Fadilah Abdul, Ankathil, Ravindran
Format: Artigo
Langue:Inglês
Publié: PAGEPress Publications 2012
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3555211/
https://ncbi.nlm.nih.gov/pubmed/23355941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2012.e23
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires